Interaction between human IgD and ricinus agglutinin

Area of Science:

• Immunology
• Biochemistry
• Glycobiology

Background:

• Immunoglobulin D (IgD) is a unique antibody isotype with a distinct structure and function.
• Understanding IgD's molecular interactions is key to characterizing its role in B cell development and immune responses.
• Specific binding partners for IgD are not extensively documented, limiting purification and functional studies.

Purpose of the Study:

• To identify specific binding partners for monoclonal immunoglobulin D (IgD).
• To characterize the molecular basis of IgD-lectin interactions.
• To develop an affinity purification method for monoclonal IgD.

Main Methods:

• Affinity chromatography using RcAI-Sepharose 4B.
• Inhibition assays with various sugars (galactose, lactose, glucose).
• Characterization of monoclonal IgD-ricinus agglutinin (RcAI) interaction.

Main Results:

• Monoclonal IgD demonstrated specific binding to ricinus agglutinin (RcAI).
• The IgD-RcAI interaction was inhibited by galactose and lactose, but not glucose.
• Galactose-containing carbohydrate units in or near the IgD sigma-hinge region mediate this interaction.
• Affinity chromatography successfully isolated monoclonal IgD from myeloma plasma.

Conclusions:

• Ricinus agglutinin (RcAI) is a specific binding partner for monoclonal IgD.
• The binding is mediated by galactose residues within the IgD molecule, likely in the sigma-hinge region.
• RcAI-Sepharose 4B is an effective tool for purifying monoclonal IgD from complex biological samples like myeloma plasma.